Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 25,807 $ 8,408
Restricted cash 250
Marketable debt securities, available for sale 3,543 8,779
Marketable equity securities, at fair value 76
Accounts receivable, net 36,694 37,708
Inventory, net 4,680 4,600
Prepaid expenses and other current assets 1,831 1,496
Total current assets 72,555 61,317
Property, plant and equipment, net 6,440 5,947
Prepaid expenses, net of current portion 251 460
Right-of-use asset, net 4,319 4,402
Intangible assets, net 10,143 10,852
Goodwill 5,709 5,709
Other assets 248 608
TOTAL ASSETS 99,665 89,295
Current liabilities    
Accounts payable 8,204 7,026
Accrued diagnostic services 1,012 1,890
Accrued advertising and other allowances 95 104
Lease liabilities 654 663
Deferred revenue 2,246 2,034
Income tax payable 4,285 1,312
Other current liabilities 3,274 2,495
Total current liabilities 19,770 15,524
Non-current liabilities:    
Deferred revenue, net of current portion 858 905
Deferred tax liability 443
Note payable 18 44
Unsecured convertible promissory notes, net 7,997 9,996
Lease liabilities, net of current portion 4,134 4,198
Total non-current liabilities 13,450 15,143
Total liabilities 33,220 30,667
COMMITMENTS AND CONTINGENCIES
Stockholders’ equity    
Preferred stock authorized 1,000,000, $0.0005 par value, no shares issued and outstanding
Common stock authorized 50,000,000, $0.0005 par value, 15,485,900 and 15,485,900 shares outstanding, respectively 16 16
Additional paid-in capital 105,634 104,552
Retained earnings 10,490 2,642
Treasury stock, at cost, 17,018,846 and 16,818,846 shares, respectively (49,557) (48,407)
Accumulated other comprehensive loss (138) (175)
Total stockholders’ equity 66,445 58,628
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 99,665 $ 89,295